Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis-Reference-Cited by-同舟云学术

Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis

Published:2018-08-16 Issue:9 Volume:70 Page:1373-1384
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Pauling John D.¹,Domsic Robyn T.²,Saketkoo Lesley A.³,Almeida Celia⁴,Withey Jane⁵,Jay Hilary⁵,Frech Tracy M.⁶^ORCID,Ingegnoli Francesca⁷^ORCID,Dures Emma⁴,Robson Joanna⁴,McHugh Neil J.¹,Herrick Ariane L.⁸,Matucci-Cerinic Marco⁹,Khanna Dinesh¹⁰,Hewlett Sarah⁴

Affiliation:

1. Royal National Hospital for Rheumatic Diseases (at Royal United Hospitals), and University of Bath; Bath UK

2. University of Pittsburgh Medical Center; Pittsburgh Pennsylvania

3. Tulane University School of Medicine; New Orleans Louisiana

4. University of the West of England; Bristol UK

5. Royal National Hospital for Rheumatic Diseases (at Royal United Hospitals); Bath UK

6. University of Utah and Salt Lake Regional Veterans Affairs Medical Center; Salt Lake City

7. University of Milano; Milano Italy

8. University of Manchester, Salford Royal Hospital NHS Foundation Trust, and Manchester Academic Health Science Centre; Manchester UK

9. University of Florence; Florence Italy

10. University of Michigan; Ann Arbor

Funder

Scleroderma Clinical Trials Consortium

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Wiley

Subject

Rheumatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.23475/fullpdf

Reference34 articles.

1. Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis;Botzoris;Joint Bone Spine,2011

2. Prevalence of Raynaud's phenomenon in a healthy Greek population;Voulgari;Ann Rheum Dis,2000

3. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database;Walker;Ann Rheum Dis,2007

4. Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey;Bassel;Rheumatology (Oxford),2011

5. Frequency and impact of disease symptoms experienced by patients with systemic sclerosis from five European countries;Willems;Clin Exp Rheumatol,2014

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease;Seminars in Arthritis and Rheumatism;2024-10

2. The 2024 British Society for Rheumatology guideline for management of systemic sclerosis;Rheumatology;2024-09-11

3. Raynaud-szindróma, 2024;Orvosi Hetilap;2024-04-28

4. Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group;Seminars in Arthritis and Rheumatism;2024-04

5. Psychological factors in symptom severity and quality of life in Raynaud’s phenomenon;Behavioural and Cognitive Psychotherapy;2024-01-29